Clinical diagnostics and therapy monitoring in the congenital disorders of glycosylation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-4986
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical diagnostics and therapy monitoring in the congenital disorders of glycosylation ; volume:33 ; number:3 ; day:7 ; month:1 ; year:2016 ; pages:345-358 ; date:6.2016
Glycoconjugate journal ; 33, Heft 3 (7.1.2016), 345-358, 6.2016
- Urheber
-
Scherpenzeel, Monique Van
- Beteiligte Personen und Organisationen
-
Willems, Esther
Lefeber, Dirk J.
SpringerLink (Online service)
- DOI
-
10.1007/s10719-015-9639-x
- URN
-
urn:nbn:de:1111-2016060330620
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Scherpenzeel, Monique Van
- Willems, Esther
- Lefeber, Dirk J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Congenital Disorders of Glycosylation (CDG): A Rapidly Expanding Group of Neurometabolic Disorders
Clinical glycomics for the diagnosis of congenital disorders of glycosylation
Epidemiology of congenital disorders of glycosylation (CDG)—overview and perspectives
Congenital disorders of glycosylation: narration of a story through its patents
Congenital disorders of glycosylation (CDG): state of the art in 2022
Modeling hypo-N-glycosylation in medaka, Oryzias latipes, to decipher mechanisms of Congenital Disorders of Glycosylation
Verbesserte Diagnostik des CDG (congenital disorders of glycosylation) durch Untersuchung mehrerer Glykoproteine
Abnormal expression of lysosomal glycoproteins in patients with congenital disorders of glycosylation
Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective
GMPPB-congenital disorders of glycosylation associate with decreased enzymatic activity of GMPPB
Disposable Passive Electrochemical Microfluidic Device for Diagnosis of Congenital Disorders of Glycosylation
Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation
Congenital Disorders of Glycosylation (CDG): A Rapidly Expanding Group of Neurometabolic Disorders
Clinical glycomics for the diagnosis of congenital disorders of glycosylation
Epidemiology of congenital disorders of glycosylation (CDG)—overview and perspectives
Congenital disorders of glycosylation: narration of a story through its patents
Congenital disorders of glycosylation (CDG): state of the art in 2022
Modeling hypo-N-glycosylation in medaka, Oryzias latipes, to decipher mechanisms of Congenital Disorders of Glycosylation
Verbesserte Diagnostik des CDG (congenital disorders of glycosylation) durch Untersuchung mehrerer Glykoproteine
Abnormal expression of lysosomal glycoproteins in patients with congenital disorders of glycosylation
Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective
GMPPB-congenital disorders of glycosylation associate with decreased enzymatic activity of GMPPB
Disposable Passive Electrochemical Microfluidic Device for Diagnosis of Congenital Disorders of Glycosylation
Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation
Congenital Disorders of Glycosylation (CDG): A Rapidly Expanding Group of Neurometabolic Disorders
Clinical glycomics for the diagnosis of congenital disorders of glycosylation
Epidemiology of congenital disorders of glycosylation (CDG)—overview and perspectives
Congenital disorders of glycosylation: narration of a story through its patents
Congenital disorders of glycosylation (CDG): state of the art in 2022
Modeling hypo-N-glycosylation in medaka, Oryzias latipes, to decipher mechanisms of Congenital Disorders of Glycosylation
Verbesserte Diagnostik des CDG (congenital disorders of glycosylation) durch Untersuchung mehrerer Glykoproteine
Abnormal expression of lysosomal glycoproteins in patients with congenital disorders of glycosylation
Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective
GMPPB-congenital disorders of glycosylation associate with decreased enzymatic activity of GMPPB
Disposable Passive Electrochemical Microfluidic Device for Diagnosis of Congenital Disorders of Glycosylation